CK Crompton Cp

"UPDATE: Realogy IPO Prices $1.08 Billion IPO at High End of Expected Range," published at 7:31 p.m. EDT Wednesday, misstated the pricing of Kythera Biopharmaceuticals Inc.'s initial public offering in the 13th paragraph. The IPO priced at $16, not $15.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires